ASIA unversity:Item 310904400/16751
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 93288/109022 (86%)
造访人次 : 20900526      在线人数 : 250
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    题名: Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma
    作者: 蔡進發;Jeffrey, J.P.Tsai;胡若梅;Hu, Rouh-Mei
    贡献者: 生物與醫學資訊學系
    关键词: Human hepatocellular carcinoma;Immunohistochemistry;Prognosis;p39;CDK5R2
    日期: 2010-10
    上传时间: 2012-11-23 17:16:35 (UTC+8)
    摘要: The aims of this study are to investigate the relationship between p39 expression and clinicopathological parameters of hepatocellular carcinoma (HCC) and to evaluate the prognostic value of p39 for HCC patients. Real-time quantitative PCR and immunohistochemistry was used to measure p39 expression in tumor and adjacent nontumor samples. Relationships of p39 expression with clinical parameters and patient survival were analyzed. Real-time quantitative RT–PCR showed that the quantity of p39 mRNA in cancerous tissue was significantly lower than that in nontumor tissue (P < 0.001). Immunohistochemistry data confirmed that p39 protein was reduced in 64% of HCC. p39 expression was not influenced by chronic alcohol exposure or cirrhosis. Reduction in p39 was correlated with the HBV (P = 0.039), HCV (P = 0.011), and histological grade (P < 0.001). HCC patients with lower p39 expression had poorer overall survival rate than that with high expression (HR, 2.868; 95% CI, 1.451–5.670; P = 0.002). Together with other results, these results reveal that p39 expression was reduced in HCC tissue. p39 could be a useful clinical prognostic marker for hepatocellular carcinoma patients.
    显示于类别:[生物資訊與醫學工程學系 ] 期刊論文


    档案 描述 大小格式浏览次数


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈